This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: University of Cambridge, Astrazeneca Ab. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 439 
1 out of 1,534 
Years Active: 2024-2025
Title: The Innovations of David Robert Spring
Introduction
David Robert Spring is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceuticals, holding two patents that showcase his innovative spirit and expertise.
Latest Patents
His latest patents include "Linkers and conjugates," which describes a conjugate comprising a protein or peptide, a linker, and an active agent. The linker features a specific moiety formula that plays a crucial role in the conjugate's functionality. Another patent, "Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof," provides a compound formula that includes a pharmaceutical composition with potential therapeutic applications.
Career Highlights
David has worked with prominent companies such as Cambridge Enterprise Limited and AstraZeneca. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Marko Juhana Hyvonen and Paul Brear. Their collaboration has likely fostered a creative environment that encourages the development of groundbreaking inventions.
Conclusion
David Robert Spring's contributions to innovation in pharmaceuticals are evident through his patents and career achievements. His work continues to impact the field positively, showcasing the importance of creativity and collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile